Collegium Pharmaceutical Inc CEO Joseph Ciaffoni Sells Company Shares
On December 21, 2023, Joseph Ciaffoni, President and CEO of Collegium Pharmaceutical Inc (NASDAQ:COLL), executed a sale of 4,357 shares of the company.
Stay updated with breaking news from Fairly Valued. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On December 21, 2023, Joseph Ciaffoni, President and CEO of Collegium Pharmaceutical Inc (NASDAQ:COLL), executed a sale of 4,357 shares of the company.
John L. Garrison Jr., Chairman and CEO of Terex Corp (NYSE:TEX), executed a sale of 45,000 shares in the company on December 19, 2023, according to a recent SEC filing.
On December 20, 2023, LAIRD JAMES F JR, a director at Diamond Hill Investment Group Inc (NASDAQ:DHIL), executed a sale of 3,000 shares of the company's stock, as reported in a SEC Filing.
Thomas Ward, Senior Vice President & President - RS&I Group of Snap-on Inc, executed a sale of 22,551 shares in the company on December 20, 2023, according to a SEC Filing.
On December 19, 2023, Frederic Simon, a director at JFrog Ltd (NASDAQ:FROG), sold 35,000 shares of the company's stock, according to a SEC Filing.